U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Zonal Outlook (East North Central, West South Central, South Atlantic, North East, East South Central, West North Central, Pacific Central, Mountain States), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: May 2020  |  Report ID: GMI2641  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2019

Summary Table of Contents Industry Coverage Methodology

Industry Trends

U.S. Home Infusion Therapy Market size was valued at over USD 8.4 billion in 2019 and will grow at over 10.1% CAGR from 2020 to 2026. Infusion therapy is a process in which patients receive medications via catheters or needles in a vein. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologics to an individual at home.

U.S. Home Infusion Therapy Market

Get more details on this report - Request Free Sample PDF

The components required to conduct home infusion include drug, equipment and supplies. The home infusion therapy is a cost-effective process that is prescribed for critical infections and specialized medical conditions when oral medications are less effective.

Increasing prevalence of chronic diseases in elderly population is one of the major factors boosting the growth of U.S. home infusion therapy market. Growing number of hospital acquired infections including contaminated equipment, bed linens and air droplets across healthcare facilities, has witnessed a surge in the adoption of home infusion therapy. In addition, introduction of new technologies coupled with presence of homecare facilities will positively impact to the market growth thereby, supporting industry expansion.

Growing geriatric population prone to chronic diseases and increasing prevalence of urinary tract infections will boost the market growth

Rapidly growing geriatric population in the U.S. is one of the major drivers for the market growth. For instance, according to a recently published data by the U.S. Department of Health and Human Services, there are more than 49.2 million people above the age of 65 across the country. The number of graying Americans has increased by around 33% over the past decade. As home infusion therapy helps to manage chronic conditions of the elderly population, the market will witness significant growth in the future.

The intravenous antibiotics treatment is amongst the frequently used home infusion therapies and is prescribed for cellulitis, sepsis, urinary tract infections and other medical conditions. Thus, increasing prescriptions of intravenous antibiotics will assist in the market growth positively.

For instance, as per a recent news article, urinary tract infections contribute for around 6 million patient visits to physicians each year in the U.S. Thus, a large patient pool across the country requiring home infusion therapy will generate high demand over the forecast period. In addition, acceptance of new technologies in the home infusion therapy market will support the industry growth.

Increasing number of patients suffering from diabetes will prove beneficial for the segmental growth

U.S. Home Infusion Therapy Market Size

Get more details on this report - Request Free Sample PDF

The infusion pump segment was valued at around USD 4.3 billion in 2019 and is expected to project a considerable market growth rate over the analysis timeframe. The factors such as growing volume of surgical procedures and rising demand for ambulatory infusion pumps will contribute to the segmental growth thereby, augmenting the overall market growth.

Also, increasing incidences of chronic diseases requiring infusion pumps will enhance the demand for home infusion therapy in the upcoming years. For instance, as per the recent news article, over 29.1 million people in the U.S. are suffering from diabetes. Thus, the above mentioned factors will stimulate the demand for smart and portable insulin pumps for diabetes management at home thereby, spurring the market growth.

Cost efficiency and low risk associated with enteral nutrition will impel the segmental growth thereby, enhancing the market growth

The enteral nutrition segment held a market share of around 25% in 2019 and is anticipated to witness substantial growth over the forecast timeframe. Increasing prevalence of cardiovascular diseases that require longer hospital stay and recovery time will increase the demand for home infusion therapy over the analysis period.  In addition, owing to factors such as cost efficiency and low risk associated with the enteral nutrition, the segment will witness substantial market growth in the future thereby, generating the demand for home infusion therapy.

Availability of home infusion therapy providers coupled with increasing number of government initiatives will enhance the market growth

U.S. Home Infusion Therapy Market Share

Get more details on this report - Request Free Sample PDF

North East U.S. region held a significant share of home infusion therapy market in 2019 and is anticipated to expand at a CAGR of 10.4% in the projected years. Surge in the number of pharmacies providing home infusion therapies is one of the major factors boosting the country growth thereby, fostering the overall market growth. For instance, Option Care Health is one of the home infusion therapy providers that caters to services such as anti-infective, nutrition support, heart failure, chronic inflammatory disorders and many more.

The high quality and cost-effective therapeutic services will provide benefits to the patients thereby, minimizing the hospital stays and risk of nosocomial infections. Thus, these factors will in turn boost the market growth. Furthermore, increasing average income of U.S. population will enhance the adoption of home infusion therapy thereby, spurring the market growth positively.

Pacific Central home infusion therapy market was valued at USD 1.3 billion in 2019 and is estimated to project significant market growth over the analysis period. Increasing number of government initiatives related to the cost efficiency of home infusion therapies for older inhabitants is one of the major factors that will positively impact the market growth.

For instance, according to a 21st Century Cures Act, the Medicare home infusion therapy benefit is for the coverage of home infusion therapy related services for particular drugs and biologics that are administered intravenously or subcutaneously to the patients. Thus, such health insurance program will boost the demand for home infusion therapy in the upcoming years thereby, augmenting the industry growth.

Implementation of several strategies such as new product launches and acquisitions by the major industry players will contribute to the market growth

Some of the prominent market players in the U.S. home infusion therapy market share are Amsino International, Baxter International, Becton Dickinson, Halyard Health, ICU Medical, Moog and Smiths Medical, among others. These market players are majorly focusing on various strategies such as collaborations, new product launches, acquisitions, and partnerships.

Recent industry developments:

  • In April 2018, Smiths Medical launched new CADD-Solis wireless infusion pump that delivers pain medication to the patients. This product attracted new customers to the company and further assisted in company growth thereby, supporting the expansion of home infusion therapy industry.
  • In October 2016, Pharma firm Eurolife Healthcare completed the acquisition of Form-Fill-Seal (FFS) Infusion business from Baxter India, a subsidiary of Baxter International. This strategic move allowed Eurolife to consolidate its position as a prominent player in the FFS Infusions segment thereby, augmenting the industry growth.

The U.S. home infusion therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

By Product, 2015 – 2026 (USD Million)

  • Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

By Application, 2015 – 2026 (USD Million)

  • Anti-infective
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

The above information is provided for the following regions:

  • East North Central
    • Illinois
    • Indiana
    • Michigan
    • Ohio
    • Wisconsin
  • West South Central
    • Arkansas
    • Louisiana
    • Oklahoma
    • Texas
  • South Atlantic
    • Delaware
    • Florida
    • Georgia
    • Maryland
    • North Carolina
    • South Carolina
    • Virginia
    • West Virginia
    • Washington, D.C.
  • North East
    • Connecticut
    • Maine
    • Massachusetts
    • New Hampshire
    • Rhode Island
    • Vermont
    • New Jersey
    • New York
    • Pennsylvania
  • East South Central
    • Alabama
    • Kentucky
    • Mississippi
    • Tennessee
  • West North Central
    • Iowa
    • Kansas
    • Minnesota
    • Missouri
    • Nebraska
    • North Dakota
    • South Dakota
  • Pacific Central
    • Alaska
    • California
    • Hawaii
    • Oregon
    • Washington
  • Mountain States
    • Arizona
    • Colorado
    • Utah
    • Nevada
    • New Mexico
    • Idaho
    • Montana
    • Wyoming


Frequently Asked Questions (FAQ) :

The market size of U.S. home infusion therapy exceeded USD 8.4 billion in 2019.
The industry share of U.S. home infusion therapy is projected to grow at 10.1% CAGR from 2020 to 2026.
Pacific Central home infusion therapy industry was valued at USD 1.3 billion in 2019, says this GMI report.
North East U.S. region is anticipated to expand at a CAGR of 10.4% through 2026.
The enteral nutrition segment held a market share of around 25% in 2019.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: May 2020
  • Pages: 250
  • Tables: 292
  • Charts / Figures: 15
  • Companies covered: 10
  • Countries covered: 51

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X